Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
LAZR
4976
DELISTED
Luminar Technologies
LAZR
| $596 | ﹤0.01% |
7,463
-56,862
| -88% | -$74.4K |
2022 Q1
15 quarters
|
|
|
LB
4977
LandBridge Co
LB
$2.48B
| $588 | ﹤0.01% |
12
| – | – |
2024 Q4
4 quarters
|
|
|
AD
4978
Array Digital Infrastructure
AD
$2.97B
| $579 | ﹤0.01% |
13
-106
| -89% | -$5.23K |
2013 Q2
50 quarters
|
|
|
BLDP
4979
Ballard Power Systems
BLDP
$720M
| $544 | ﹤0.01% |
214
-20,300
| -99% | -$63K |
2020 Q2
22 quarters
|
|
|
NUVB.WS
4980
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
| $541 | ﹤0.01% |
1,638
| – | – |
2022 Q1
15 quarters
|
|
4981
Stem
STEM
$41M
| $497 | ﹤0.01% |
33
| – | – |
2022 Q1
15 quarters
|
|
4982
Ebang International Holdings
EBON
$13.1M
| $493 | ﹤0.01% |
161
| – | – |
2023 Q3
9 quarters
|
|
4983
Main Street Capital
MAIN
$5.15B
| $483 | ﹤0.01% |
8
+4
| +100% | +$236 |
2024 Q2
6 quarters
|
|
4984
Paymentus
PAY
$3.88B
| $474 | ﹤0.01% |
15
-2
| -12% | -$65 |
2023 Q2
10 quarters
|
|
|
OPENW
4985
Opendoor Technologies Inc Series K Warrants
OPENW
$3.97M
| $474 | ﹤0.01% |
+527
| New | +$711 |
2025 Q4
0 quarters
|
|
4986
Unicycive Therapeutics
UNCY
$118M
| $462 | ﹤0.01% |
80
| – | – |
2025 Q2
2 quarters
|
|
4987
iShares MSCI Sweden ETF
EWD
$942M
| $443 | ﹤0.01% |
9
| – | – |
2022 Q1
15 quarters
|
|
|
CRON
4988
Cronos Group
CRON
$1.19B
| $408 | ﹤0.01% |
155
| – | – |
2024 Q3
5 quarters
|
|
4989
FT Vest US Equity Moderate Buffer ETF April
GAPR
$296M
| $400 | ﹤0.01% |
10
-2,217
| -100% | -$87.6K |
2024 Q3
5 quarters
|
|
|
OPENL
4990
Opendoor Technologies Inc Series A Warrants
OPENL
$2.68M
| $373 | ﹤0.01% |
+717
| New | +$612 |
2025 Q4
0 quarters
|
|
|
JNEU
4991
AllianzIM U.S. Equity Buffer15 Uncapped June ETF
JNEU
$41.2M
| $303 | ﹤0.01% |
10
-4,950
| -100% | -$150K |
2025 Q1
3 quarters
|
|
4992
Mitsubishi UFJ Financial
MUFG
$257B
| $270 | ﹤0.01% |
17
-273
| -94% | -$4.22K |
2024 Q3
5 quarters
|
|
|
NA
4993
Nano Labs
NA
$48.4M
| $239 | ﹤0.01% |
76
| – | – |
2023 Q3
9 quarters
|
|
|
MIMI
4994
Mint Inc
MIMI
$13.1M
| $235 | ﹤0.01% |
78
| – | – |
2025 Q3
1 quarter
|
|
4995
Immunic
IMUX
$109M
| $217 | ﹤0.01% |
41
+3
| +8% | +$22 |
2024 Q4
4 quarters
|
|
|
BBBYW
4996
Neighborhood Intelligence Inc Warrants
BBBYW
$2.55M
| $213 | ﹤0.01% |
+323
| New | +$307 |
2025 Q4
0 quarters
|
|
|
OPENZ
4997
Opendoor Technologies Inc Series Z Warrants
OPENZ
$2.59M
| $210 | ﹤0.01% |
+527
| New | +$319 |
2025 Q4
0 quarters
|
|
|
ZK
4998
DELISTED
Zeekr
ZK
| $208 | ﹤0.01% |
134
-21,666
| -99% | -$607K |
2024 Q2
6 quarters
|
|
|
SHCO
4999
DELISTED
Soho House & Co
SHCO
| $206 | ﹤0.01% |
23
-4
| -15% | -$35 |
2022 Q1
15 quarters
|
|
5000
Ramaco Resources Class B
METCB
$276M
| $200 | ﹤0.01% |
18
| – | – |
2023 Q2
10 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.